The 29th International Symposium of Intensive Care and Emergency Medicine in Brussels was again the information hub for latest research. SIRS-Lab wants to thank its guests for visiting our booth and sharing discussions. In spring, more event highlights on molecular diagnostics and intensive care are coming up.
more »

SIRS-Lab congratulates its founding shareholder and chairman of the scientific advisory board Prof. Konrad Reinhart on the reception of the Research Award Thuringia. For further details...
more »

SIRS-Lab is pleased to announce the appointment of Ania Mitan as Executive Vice President Commercial. This expansion of the senior management accelerates the routine implementation of SIRS-Lab’s breakthrough diagnostic suite for sepsis. In her capacity, Ania Mitan will be responsible for commercial planning and execution as well as business development.
more »

PD Dr. Thomas Vogl from the University in Münster, Germany, received the "Hugo Schottmüller Award" from the German Sepsis Society. The Award donated by SIRS-Lab values excellent achievements in basic research about sepsis. Hugo Schottmüller was the first to define the Sepsis as clinical disease in 1914.
more »

SIRS-Lab today announced that the EU regulatory authorities have granted the CE mark for VYOO. With VYOO, clinicians can rapidly and reliably identify causative pathogens as well as important antibiotic resistance markers. The CE mark will accelerate the implementation of VYOO into clinical routine throughout Europe.
more »

In a blinded peer review by worldwide leading experts in sepsis research, SIRS-Lab’s diagnostic concept for the early prediction and reliable monitoring of sepsis was awarded best scientific submission of the SEPSIS 2008 Symposium.
more »

SIRS-Lab today announced its Quality Management certification for in-vitro diagnostics. After building up a new production suite, the company now accelerates the further clinical routine implementation of its molecular diagnostic tests for sepsis.
more »

SIRS-Lab today announced to foster clinical research- and exchange projects at the medical faculty of the University Jena. With the funding, the company wants to recognize outstanding achievements of young scientists in sepsis research. The funding was presented at SIRS-Lab's "Innovation Reception Lifescience"
more »

SIRS-Lab announced the closing of a follow up financing round led by Affentranger Associates SA alongside with bm-t beteiligungsmanagement thüringen. This new round aims at a rapid ramp up of SIRS-Lab’s sales and marketing organization.
more »

SIRS-Lab introduces a new diagnostic concept for the early prediction and reliable monitoring of sepsis. The molecular diagnostic test “SIQNATURE” delivers the earliest possible information about the potential development of a systemic infection. It further is a unique tool to monitor the progression of sepsis.
more »

SIRS-Lab GmbH and the Institute for Medical Microbilogy from the Jena University were jointly awarded with the IQ Innovation Award of central Germany. Additionally, the company and its partners received the cluster award “Biotechnology and Lifescience” and the regional award of Jena. The jury underlined the social and economical relevance of the clinical diagnostic system VYOO, for which SIRS-Lab received the award.
more »

In the course of the International Shock Congress (Cologne June 28 – July 2), SIRS-Lab will host the cutting edge workshop “Microarray – Tool or Toy”. Register now for the congress and join the workshop with lectures from: Michael Bauer, Peter Biberthaler, Friedemann Horn, Matthias Kohl, Chris Thiemermann, and Yoram Vodovotz. Read more about the workshop program, registration (discount prior to April 15), and the congress here…
more »

SIRS-Lab published a new Application Note of its Sepsis test VYOO. Objective of the study was to compare VYOO with current standard methods for pathogen detection in sepsis. The results show the competitive sensitivity and specificity of the molecular sepsis solution. Download the...
more »

The R&D collaboration with the University Hospital Jena and the University of Applied Science Jena is valued with the Thuringian Innovation Award 2007. The awarded core innovation is LOOXSTER's ability to concentrate fungal DNA. With VYOO, sepsis specific bacterial and fungal species can then be detected. The Jury, consisting of high representatives from science and business organizations...
more »

miRNA analysis now available: SIRS-Lab’s gene expression profile is now extended with the accurate measurement of regulatory RNA. The new Illumina MicroRNA Expression Profiling Panels enable the analysis of all currently known miRNAs, an important class of regulatory RNA.
more »

The VYOO™ Roadshow continues. SIRS-Lab will attend the DGHM in Göttingen, Germany from Sunday Oct 1st till Thursday Oct 4th. SIRS-Lab’s team is looking forward to meeting you there. At the same time, Oct 1st, Dr. Britta Wlotzka visits the Edinburgh University to talk at the seminar “Multiparameter Detection and Diagnostics". For more information on the meetings, please...
more »

The prize is awarded by the German Sepsis Society for exceptional achievements in Sepsis research. At the 3rd International Congress Sepsis and Multiorgan Dysfunction in Weimar, Dr. S. Wirtz from the University Hospital Mainz, Germany, received this year’s award which is endowed by SIRS-Lab with 3000 Euro.
more »